{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial pulmonary fibrosis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_abatacept",
          "name": "Abatacept"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_anakinra",
          "name": "Anakinra"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_daclizumab",
          "name": "Daclizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_pirfenidone",
          "name": "Pirfenidone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_teriflunomide",
          "name": "Teriflunomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_abatacept",
          "type": "Drug",
          "label": "Abatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_anakinra",
          "type": "Drug",
          "label": "Anakinra",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_daclizumab",
          "type": "Drug",
          "label": "Daclizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nintedanib",
          "type": "Drug",
          "label": "Nintedanib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pirfenidone",
          "type": "Drug",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_teriflunomide",
          "type": "Drug",
          "label": "Teriflunomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_familial_pulmonary_fibrosis",
          "type": "Disease",
          "label": "Familial pulmonary fibrosis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_abatacept",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知对肺纤维化患者可能有不良反应"
        },
        {
          "source": "n_adalimumab",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与其他生物制剂相似的潜在风险"
        },
        {
          "source": "n_anakinra",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已显示对相似病理产生负面影响"
        },
        {
          "source": "n_azathioprine",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "潜在的肺纤维化加重风险"
        },
        {
          "source": "n_bosentan",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "对肺部的负面药理作用常识"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能导致纤维化相关并发症"
        },
        {
          "source": "n_daclizumab",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "潜在的免疫调节失衡"
        },
        {
          "source": "n_methotrexate",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "流行病学数据表明风险"
        },
        {
          "source": "n_nintedanib",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "适应症与肺纤维化相关"
        },
        {
          "source": "n_pirfenidone",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有关于肺纤维化的双向数据"
        },
        {
          "source": "n_rituximab",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "对肺部的作用具有潜在风险"
        },
        {
          "source": "n_teriflunomide",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能引发与纤维化相关的反应"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物与家族性肺纤维化存在明显禁忌关系",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物在特定患者群体中具有相似的机制和反应"
    ],
    "uncertainties": [
      "药物的具体不良反应尚需针对特定个案进一步研究"
    ],
    "next_focus_for_pi": [
      "是否需要添加进一步的临床案例支持数据？"
    ]
  }
}